Advanced Life Sciences Holdings of Woodridge, Illinois, has outlined plans to go public with an offering of 6.4 million shares at $5 per share. Advanced Life Sciences has been developing drugs for infection, cancer and inflammation. Its lead candidate, cethromycin, is a ketolide antibiotic in late-stage clinical development for the treatment of respiratory tract infections.
- read this press release for more